Episode
How AI Is Detecting Lung Cancer From Low-Dose CT Scans
- Published
- Jun 13, 2026
- Duration seconds
- 612
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/healthtech-talks-with-fexingo-digital-health-telemedicine-and-medical-software-7871821/episodes/how-ai-is-detecting-lung-cancer-from-low-dose-ct-scans/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/healthtech-talks-with-fexingo-digital-health-telemedicine-and-medical-software-7871821/how-ai-is-detecting-lung-cancer-from-low-dose-ct-scans.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Healthtech Talks, Lucas and Luna explore how artificial intelligence is being deployed to detect lung cancer earlier and more accurately from low-dose CT scans. They focus on a specific 2024 study from the Journal of Clinical Oncology that found AI screening reduced false positives by 40 percent compared to radiologist-only reads. The hosts break down the numbers: the 10,000-patient trial, the 24 percent improvement in detection of stage 1 nodules, and what this means for the 160,000 annual lung cancer deaths in the US. They also discuss the practical deployment challenges — integration into existing PACS systems, radiologist workflow acceptance, and training data bias. Plus, a brief look at how Google Health and a startup called Optellum are competing in this space. The episode is grounded in real data and avoids hype, giving listeners a clear picture of where AI stands in one of the most promising applications in cancer diagnostics. #AI #LungCancer #Healthtech #MedicalAI #CTScans #Radiology #EarlyDetection #CancerScreening #Optellum #GoogleHealth #BusinessAndTechnology #HealthtechTalks #FexingoBusiness #BusinessPodcast #LucasAndLuna #DiagnosticAI #Oncology #MachineLearning Keep every episode free: buymeacoffee.com/fexingo